Abiopharma

New Form 8-K - Ultragenyx Pharmaceutical Inc. Filed: 2025-08-05 AccNo: 0000950170-25-103026 Size: 537 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Biomea Fusion, Inc. Filed: 2025-08-05 AccNo: 0000950170-25-103023 Size: 358 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - MYRIAD GENETICS INC Filed: 2025-08-05 AccNo: 0000899923-25-000084 Size: 751 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Day One Biopharmaceuticals, Inc. Filed: 2025-08-05 AccNo: 0000950170-25-103012 Size: 12 MB

New Form 8-K - HALOZYME THERAPEUTICS, INC. Filed: 2025-08-05 AccNo: 0001159036-25-000033 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Spyre Therapeutics, Inc. Filed: 2025-08-05 AccNo: 0001636282-25-000089 Size: 9 MB

New Form 6-K - Stevanato Group S.p.A. Filed: 2025-08-05 AccNo: 0000950170-25-103009 Size: 12 MB

New Form 4 - XWELL, Inc. Filed: 2025-08-05 AccNo: 0001104659-25-074168 Size: 5 KB

New Form SCHEDULE 13G - Scorpius Holdings, Inc. Filed: 2025-08-05 AccNo: 0001753926-25-001234 Size: 23 KB

New Form D - ProPhase Labs, Inc. Filed: 2025-08-05 AccNo: 0001641172-25-022239 Size: 9 KB